|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2001;72:1441
© 2001 The Society of Thoracic Surgeons
a Department of Chest Surgery, Fukui Red Cross Hospital, 2-4-1 Tsukimi, Fukui 918-8501, Japan
e-mail: akiray{at}mitene.or.jp
To the Editor
We thank Dr Brühlmann for suggesting embolotherapy as a less invasive alternative treatment. There are several surgical procedures available for this rare disease depending on the clinical features. Regarding the pathology, there is an incomplete type with a dual (systemic and pulmonary artery) blood supply to the affected segments [1]. We agree that ligation of the anomalous arteries can be done only in patients with a normal pulmonary artery blood supply. In general, we also agree that embolotherapy can be recommended as a less invasive therapy for such patients.
We suggest two points to keep in mind when embolotherapy is being considered: the risk of a small therapeutic embolus escaping to the left circulation in patients with arteriovenous malformation [2] and the need of angiography from the descending thoracic aorta through the abdominal aorta. Anomalous arteries tend to arise from the abdominal aorta in patients with a dual arterial blood supply, and two or more anomalous arteries can coexist [1].
As less invasive surgical therapy, ligation or severance of the anomalous arteries can be achieved only with VATS (video-assisted thoracoscopic surgery). If embolotherapy produces incomplete occlusion or if arterialization recurs despite embolotherapy, VATS can still be applied.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |